Skip Navigation
November 3, 2009

Study author discusses ACP guideline on the benefit and risks of PED-5 Inhibitor Drugs for patients suffering from erectile dysfunction.

Running Time: (1:41)

×

You need a subscription to this content to use this feature.

×

This PDF is available to Subscribers Only